Source: LevelJump Healthcare Corp.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • LevelJump Healthcare (JUMP) has closed a non-brokered private placement for gross proceeds of $877,000.15
  • The company issued a total of 5,858,334 units priced at $0.15 per unit
  • Leveljump Healthcare is a healthcare company with a focus on profitable telehealth solutions as well as primary care services in radiology
  • Net proceeds will be used for acquisitions and for general working capital
  • Shares in Leveljump Healthcare Corp. (JUMP) opened trading at C$0.11

LevelJump Healthcare (JUMP) has closed its previously announced non-brokered private placement for gross proceeds of $877,000.15.

The company issued a total of 5,858,334 units priced at $0.15 per unit. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to acquire one additional common share until January 31, 2024.

Net proceeds will be used for acquisitions and for general working capital.

All securities issued will be subject to a four-month holding period.

Leveljump Healthcare is a healthcare company with a focus on profitable telehealth solutions as well as primary care services in radiology. The company provides radiology solutions for hospitals, emergency rooms, and private clinics.

LevelJump Healthcare Corp. (JUMP) opened trading at C$0.11.

More From The Market Herald
Small Pharma - CEO, George Tziras.

" Small Pharma (TSXV:DMT) announces NCIB

Small Pharma (DMT) has received TSXV approval for a normal course issuer bid.
Spectral Medical Inc. - CMO, Dr. John Kellum

" Spectral (TSX:EDT) gets FDA approval for Tigris trial

Spectral Medical (EDT) announced that the U.S. Food and Drug Administration (FDA) has approved ten new clinical trial sites for the Tigris trial.

" Diagnos (TSXV:ADK) receives approval for its AI enabled Pathology Detection Systems

Diagnos (ADK) has received approval from the Costa Rican regulatory agency for its Artificial Intelligence (AI) enabled Pathology Detection Systems.

" BioHarvest (CSE:BHSC) launches first major U.S marketing campaign

BioHarvest Sciences (BHSC) has announced the first multimedia campaign for VINIA in the USA, Phase 1.